Showing all 5 results
Diltiazem Tablets
FreeProduct Composition & Strength
We supply this product as Film Coated Tablets (Immediate Release) or Sustained Release (SR) Tablets (Matrix Technology).
Active Ingredient Strength Formulation Role Diltiazem HCl USP/BP 30 mg Immediate Release Initial Titration / Angina Diltiazem HCl USP/BP 60 mg Immediate Release Standard Maintenance Diltiazem HCl USP/BP 90 mg / 120 mg Sustained Release (SR) Twice Daily Control Excipients Q.S. HPMC (Release Matrix) / Lactose Controlled Diffusion Metoprolol & Amlodipin Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Engineered, API-Segregated Bilayer Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu or high-density PVC/PVDC blister strips to ensure the absolute chemical stability of the combined molecules.
Active Ingredient Strength Primary Clinical Function Metoprolol (as Tartrate/Succinate ER) Ph.Eur./USP 25 mg / 50 mg Cardioselective Base: Reduces heart rate, cardiac workload, and neutralizes CCB-induced reflex tachycardia. Amlodipine (as Besylate) Ph.Eur./USP 5 mg Calcium Channel Blocker (CCB): Forces profound peripheral arterial vasodilation, dropping severe blood pressure and relieving coronary spasms. Excipients Microcrystalline Cellulose / Dibasic Calcium Phosphate / Crospovidone / Magnesium Stearate / Premium Opadry Film / Iron Oxide Colors Diluent / Stabilizing Buffer / Superdisintegrant / Lubricant (Engineered specifically using bilayer press technology to physically separate the slightly acidic Metoprolol salt from the basic Amlodipine, preventing destructive chemical cross-talk) *Pack Sizes: 10×10 Blisters (Optimized specifically for strict 30-day chronic cardiology dispensing regimens).
Nifedipine Tablet
FreeProduct Composition & Structural Formats
We manufacture Nifedipine across the complete clinical dosage spectrum, utilizing distinct release matrices calibrated for immediate stabilization or sustained, once-daily therapeutic coverage.
Active Ingredient Available Strengths Formulation Matrix Delivery System Primary Clinical Focus Nifedipine IP/BP/USP 10 mg Immediate-Release / Rapid-Onset Film Tablet Acute Titration / Tocolysis: For severe acute hypertension or suppression of premature labor contractions. Nifedipine IP/BP/USP 20 mg Sustained-Release (SR) Retard Matrix Twice-Daily Maintenance: Intermediate control for stable chronic hypertension. Nifedipine IP/BP/USP 30 mg Once-Daily Extended-Release (XR / XL) Matrix First-Line Chronic Care: Continuous 24-hour plasma stabilization for mild-to-moderate hypertension. Nifedipine IP/BP/USP 60 mg Once-Daily Extended-Release (XR / XL) Matrix High-Potency Control: For refractory essential hypertension and severe chronic stable angina pectoris. Olmesartan, Amlodipine & Hydrochlorothiazide Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Engineered, API-Segregated Film-Coated Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips to ensure the absolute chemical stability of all three active ingredients across their entire shelf life.
Active Ingredient Strength Primary Clinical Function Olmesartan Medoxomil Ph.Eur./USP 20 mg / 40 mg ARB Base: Blocks the renin-angiotensin-aldosterone system (RAAS) and provides critical diabetic renoprotection. Amlodipine (as Besylate) Ph.Eur./USP 5 mg / 10 mg CCB Vasodilator: Forces profound, sustained peripheral arterial relaxation. Hydrochlorothiazide (HCTZ) Ph.Eur./USP 12.5 mg / 25 mg Diuretic Volume Controller: Flushes excess sodium/water and massively amplifies the efficacy of the ARB component. Excipients Silicified Microcrystalline Cellulose / Pregelatinized Starch / Croscarmellose Sodium / Magnesium Stearate / Opadry Protective Film Moisture-Scavenging Diluent / Binder / Superdisintegrant / Premium Film-Coating (Engineered specifically to physically isolate the highly sensitive Olmesartan ester from the alkaline Amlodipine salt to prevent cross-degradation) *Pack Sizes: 10×10 Alu-Alu Blisters or 3×10 Unit-Dose Blisters (Optimized specifically for strict 30-day chronic cardiology dispensing regimens).
Ramipril and Amlodipine Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended Capsule or Film-Coated Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips to ensure the absolute chemical stability of the highly degradable Ramipril molecule.
Active Ingredient Strength Primary Clinical Function Ramipril Ph.Eur./USP 5 mg / 10 mg ACE inhibition for vasodilation, neurohormonal blockade, and venous pressure equalization. Amlodipine (as Besilate) Ph.Eur./USP 5 mg / 10 mg Global Clinical Standard: Sustained CCB for profound, 24-hour arterial vasodilation. Excipients Microcrystalline Cellulose / Crospovidone / Sodium Stearyl Fumarate / Hypromellose / Iron Oxide Red Diluent / Superdisintegrant / Alkaline Stabilizing Lubricant (Engineered to protect Ramipril from acidic degradation and moisture) *Pack Sizes: 10×10 Alu-Alu Blisters or 3×10 Unit-Dose Blisters (Optimized specifically for strict, high-compliance 30-day chronic cardiology dispensing regimens).
